SCHEMBL18273483

SCHEMBL18273483

c1ccc(-c2nc(-c3ccc4c(c3)c3ccccc3n4-c3ccccc3)nc3oc4ccccc4c23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.41
LMNA P02545 2/20 0.41
L3MBTL1 Q9Y468 4/20 0.39
ATM Q13315 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 5/20 0.38
NPSR1 Q6W5P4 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 3/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 1/20 0.36
HTT P42858 1/20 0.36
PTGER4 P35408 1/20 0.36
NPY5R Q15761 1/20 0.35
POLB P06746 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HSD17B10 Q99714 3/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16905972 0.99 SMN1; SMN2 (0.40) SMN1; SMN2LMNAL3MBTL1ATMKDM4E
SCHEMBL18273479 0.98 SMN1; SMN2 (0.41) SMN1; SMN2LMNAL3MBTL1ATMKDM4E
SCHEMBL18273508 0.97 SMN1; SMN2 (0.39) SMN1; SMN2LMNAL3MBTL1ATMKDM4E
SCHEMBL18273514 0.97 SMN1; SMN2 (0.39) SMN1; SMN2LMNAL3MBTL1ATMKDM4E
SCHEMBL18273485 0.97 SMN1; SMN2 (0.38) SMN1; SMN2LMNAL3MBTL1ATMKDM4E
SCHEMBL16905844 0.97 SMN1; SMN2 (0.41) SMN1; SMN2LMNAL3MBTL1ATMKDM4E
SCHEMBL18471418 0.96 SMN1; SMN2 (0.39) SMN1; SMN2LMNAL3MBTL1ATMKDM4E
SCHEMBL16905969 0.96 SMN1; SMN2 (0.41) SMN1; SMN2LMNAL3MBTL1ATMKDM4E
SCHEMBL18273478 0.95 SMN1; SMN2 (0.39) SMN1; SMN2LMNAL3MBTL1ATMKDM4E
SCHEMBL16905833 0.95 SMN1; SMN2 (0.39) SMN1; SMN2LMNAL3MBTL1ATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160351826-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 SMN1; SMN2 4723/4885LMNA 1491/4885L3MBTL1 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.